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Abstract Zonula occludens protein 1 (ZO-1) is a cytosolic tight
junction protein that tethers transmembrane proteins such as
occludin, claudin and junctional adhesion molecule to the actin
cytoskeleton. The interaction between ZO-1 and claudin or
junctional adhesion molecule occurs via the amino-terminal
PSD95/Dlg/ZO-1 (PDZ) domains in ZO-1. A yeast two-hybrid
screen to search for proteins that interact with the PDZ domains
of ZO-1 identified connexin (Cx) 45. Cx45 interacts with the
PDZ domains of ZO-1 and ZO-3, but not ZO-2, via a short
C-terminal PDZ binding motif (SVWI). In transfected epithelial
Madin^Darby canine kidney cells, Cx45 co-localizes with
endogenous ZO-1 at or near tight junctions and co-precipitation
experiments show that Cx45 and ZO-1 directly interact.
Inactivating the C-terminal PDZ-binding motif in Cx45 affects
its co-precipitation and co-localization with ZO-1. The growing
number of connexins (i.e. Cx43 and Cx45) that can associate
with ZO proteins indicate that ZO proteins may play a more
general role in organizing gap junctions and/or in recruiting
signaling molecules that regulate intercellular communica-
tion. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Intercellular communication is paramount in allowing cells
to successfully accomplish their task in a coordinated manner
in multicellular organisms and tissues. One mechanism of in-
tercellular communication relies on the formation of gap junc-
tions, protein channels that span the lipid bilayers of adjacent
cells and thus allow the direct exchange of ions, second mes-
sengers and metabolites between neighboring cells. Gap junc-
tion permeability plays a critical role in cellular di¡erentia-
tion, development and metabolic and electrophysiological
processes (reviewed in [1^4]).
Gap junctions are composed of subunit proteins encoded by
the connexin multigene family, comprising over a dozen dis-
tinct connexin genes. Connexins span the lipid bilayer four
times, with their N- and C-termini facing the cytoplasm (re-
viewed in [5,6]). Six connexin molecules assemble into a hemi-
channel or connexon, forming a pore in the lipid bilayer.
Interaction of two connexons on adjacent cells establishes
an intercellular aqueous pore that allows the exchange of
small molecules between cells. A few to more than 105 con-
nexons aggregate into tightly packed plaques to form gap
junctions. Connexons may contain a single (homomeric con-
nexon) or multiple (heteromeric connexon) connexin types. In
addition, adjacent cells may contribute identically or di¡er-
ently composed connexons to form homotypic or heterotypic
intercellular channels. This unique feature to generate diver-
sity in terms of subunit composition, stoichiometry and dock-
ing is thought to specify the physiological properties of indi-
vidual gap junctions.
Oligomerization of connexins and assembly into connexons
occurs early in the secretory pathway [7]. How connexons are
then transported to the plasma membrane is less well under-
stood. There is ample evidence, however, that speci¢c types of
connexons can localize to specialized plasma membrane do-
mains in di¡erent cell types [1]. During oocyte maturation and
follicle development, granulosa cells extend processes to the
oocyte, leading to the formation of intermediate junctions
between the two cells. Connexin (Cx) 37 is restricted to gap
junctions between granulosa cells and the oocyte, whereas
Cx43 is found in channels linking adjacent granulosa cells
[8]. In Schwann cells, Cx32 localizes to the incisures of
Schmitt^Lanterman and the paranodal regions bordering the
nodes of Ranvier [9,10]. In cardiac myocytes, Cx43 is present
in intercalated discs [11], which connect myocytes in an end-
to-end orientation. Intercalated discs contain zonula occlu-
dens protein 1 (ZO-1), a protein present in tight junctions in
epithelial and endothelial cells. Interestingly, ZO-1 interacts
with Cx43 [11] and may thus be involved in the localization
of Cx43 to intercalated discs in myocytes.
In a search for proteins that bind to the PSD95/Dlg/ZO-1
(PDZ) domains of ZO-1 we identi¢ed Cx45 as a second mem-
ber of the connexin family to associate with ZO-1. In addition
to ZO-1, Cx45 also interacts with the PDZ domains of ZO-3,
but not with those of ZO-2. Co-precipitation and co-localiza-
tion experiments con¢rmed the interaction between ZO-1 and
Cx45. Thus, ZO proteins may play a more general role in the
assembly of connexons at particular plasma membrane do-
mains and/or in the recruitment of signaling molecules to
gap junctions.
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2. Materials and methods
2.1. Yeast two-hybrid screen
A yeast two-hybrid screen was performed using the N-terminal
three PDZ domains of human ZO-1 (amino acids 1^507) fused in
frame to the GAL4 DNA binding domain of the yeast expression
vector pGBKT7 (Clontech) as a bait and a pre-transformed mouse
17 day embryo cDNA library fused to the GAL4 transactivator do-
main in the yeast expression vector pACT2 (Clontech). All experimen-
tal details were according to the manufacturer’s protocols. Clones
obtained in a ¢rst screen at low stringency were re-screened at high
stringency with dropout media and then tested for L-galactosidase
activity. Plasmids from positive clones were isolated and the cDNA
inserts sequenced, resulting in the identi¢cation of cDNAs encoding
the C-terminal region of Cx45. The interaction was retested by trans-
forming the library plasmid encoding amino acids 315^396 of Cx45,
or a mutant in which the four C-terminal amino acids (SVWI) were
mutated to alanine, with bait vectors carrying the PDZ domains of
human ZO-1, canine ZO-2 (amino acids 1^591) or ZO-3 (amino
acids1^467). Empty pGBKT7 or a bait plasmid with a laminin
cDNA (Clontech) served as negative controls.
2.2. Cell culture and transfection of MDCK cells
Madin^Darby canine kidney (MDCK) strain II cells were cultured
and grown on permeable Transwell polycarbonate ¢lter units (Costar)
to obtain polarized cell monolayers as described [12]. The full length
human Cx45 cDNA (kindly provided by Dr. K. Willecke, Bonn,
Germany) was subcloned into the pcDNA3 expression vector and
transfected into MDCK cells using Transfast (Promega). Following
selection in G418, cells expressing Cx45 were identi¢ed by immuno-
£uorescence or Western blotting with a monoclonal mouse anti-hu-
man Cx45 antibody (Chemicon; see below).
2.3. Co-immunoprecipitation assays
Control and transfected MDCK cells expressing either wild type or
mutant Cx45 were incubated for 30 min at 37‡C with 2 Wg/ml cyto-
chalasin D (Sigma) and then cooled on ice for 30 min. After washing
with cold phosphate-bu¡ered saline (PBS), cells were lysed on ice in
lysis bu¡er containing 0.5% Triton X-100 in PBS supplemented with a
protease inhibitor cocktail. The post-nuclear supernatant was pre-
cleared and ZO-1 was immunoprecipitated with 3 Wg/ml of rabbit
anti-ZO-1 antibody (Zymed) and protein G Sepharose (Pharmacia).
Immunoprecipitates were washed with lysis bu¡er, fractionated by
SDS^PAGE (10% acrylamide) and blotted onto PVDF membranes.
Cx45 was detected using a monoclonal mouse anti-human Cx45 anti-
body (1:1000; Chemicon), followed by horseradish peroxidase-labeled
goat anti-mouse antibody (1:3000; Bio-Rad) and chemiluminescence
(Super Signal West Pico, Pierce). Autoradiographs were quantitated
by densitometry.
2.4. Immuno£uorescence labeling
MDCK cells grown on glass coverslips or 0.4 Wm Transwell ¢lters
(Costar) were ¢xed with either cold methanol (2.5 min; 320‡C) or
paraformaldehyde (PFA) (3.7%; 30 min) and, in the case of PFA
¢xation, permeabilized with Triton X-100 (0.2% in PBS). After block-
ing in 10% goat serum (Gibco BRL), cells were incubated with a
monoclonal mouse anti-human Cx45 antibody (5 Wg/ml; Chemicon)
and a rabbit anti-dog ZO-1 (1:200; Zymed) followed by Alexa 488-
and Alexa 594-labeled goat anti-mouse and anti-rabbit antibodies
(1:1000; Molecular Probes), respectively. Images were acquired using
a confocal laser scanning microscope (Bio-Rad) and IMARIS soft-
ware (Bitplane).
3. Results
3.1. The C-terminus of Cx45 interacts with the PDZ domains
of ZO-1 and ZO-3 in a yeast two-hybrid assay
To identify proteins that interact with the PDZ domains of
ZO-1, a yeast two-hybrid screen was carried out using a
mouse 17 day embryo library. Sequencing of positive clones
revealed cDNAs encoding the C-terminal coding region of
connexin 45. One Cx45 clone encoding amino acids 315^396
fused in frame to the Gal4 transactivation domain was se-
lected for further characterization. In addition to the PDZ
domains of ZO-1, the Cx45 construct interacted with the
PDZ domains of ZO-3, but not with those of ZO-2 (Table
1), indicating that Cx45 did not indiscriminately interact with
PDZ domains in general. No interactions were detected be-
tween the Cx45 construct and either laminin or an empty
library vector encoding the Gal4 DNA binding domain
alone.
PDZ domains often interact via C-terminal amino acid mo-
tifs in transmembrane proteins and the C-terminal SVWI in
Cx45 is reminiscent of type-1 PDZ binding motifs [13]. To test
whether this motif was required for the interaction with the
ZO-1 and ZO-3 PDZ domains, the four C-terminal residues
were mutated to alanine. The mutant Cx45 no longer inter-
acted with the ZO-1 PDZ domains in the two-hybrid assay
(Table 1), showing that the C-terminal SVWI in Cx45 can
bind to PDZ domains and con¢rming its importance in the
interaction with ZO-1 and ZO-3.
Together, these results show that in a yeast two-hybrid
assay, the PDZ domains in ZO-1 and ZO-3, but not those
in ZO-2, interact with Cx45 via a C-terminal SVWI PDZ
binding motif.
3.2. Characterization of epithelial MDCK cells transfected with
Cx45 cDNA
To con¢rm the two-hybrid results, we determined if full
length ZO-1 was able to bind to full length Cx45 and whether
this interaction occurred in vivo. For this purpose, epithelial
MDCK cells, which endogenously express ZO-1, were stably
transfected with mouse Cx45 or a Cx45 mutant carrying an
inactivated C-terminal PDZ binding motif. Expression of the
transfected Cx45 was characterized by Western blot analysis
and immuno£uorescence using an antibody to mouse Cx45.
Table 1
Interaction of the PDZ domains of ZO-1, ZO-2 and ZO-3 with a construct encoding the C-terminal region of Cx45 or a Cx45 mutant
(Cx45mut) in which the SVWI amino acids encoding a putative PDZ binding motif were mutated to alanine
Cx45 Cx45mut Library vector Laminin T-Ag
ZO-1 PDZ +++ 3 3 3 nd
ZO-2 PDZ 3 3 3 3 nd
ZO-3 PDZ +++ 3 3 3 nd
Bait vector 3 3 3 3 3
p53 3 3 3 3 +++
Interactions were determined by monitoring growth of co-transformed yeast on selective media and L-galactosidase activity. Similar results were
obtained under low and high stringency conditions. Empty bait (pGBKT7) and library (pACT2) plasmids and a laminin construct served as
negative controls. T-antigen (T-Ag) and p53, known to interact, were used as a positive control. Growth on dropout media and L-galactosidase
activities for yeast co-expressing T-Ag and p53 (positive control; +++) were similar for clones co-expressing the C-terminus of Cx45 and the
PDZ domains of ZO-1 and ZO-3.
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As shown in Fig. 1A, a 45 kDa band, corresponding in ap-
parent molecular weight to Cx45, was detected in cells trans-
fected with the wild type (lane 2) or the mutant (lane 3) Cx45,
but not in control MDCK cells (lane 1). The expression of
Cx45 was con¢rmed by immuno£uorescence microscopy (Fig.
1B). Cells expressing the wild type or the mutant Cx45
showed a punctate staining typical of connexons. Interest-
ingly, the wild type, but not the mutant, Cx45 was concen-
trated at sites of cell^cell contact (Fig. 1B, arrows).
3.3. Cx45 directly associates with ZO-1 in vivo
To analyze if also full length Cx45 and ZO-1 interact in
vivo, co-immunoprecipitation experiments were carried out.
MDCK cells expressing wild type or mutant Cx45 were lysed
and endogenous ZO-1 precipitated using a polyclonal anti-
body. Immunoprecipitates were then analyzed by Western
blot using an antibody to Cx45.
As shown in Fig. 2, Cx45 was co-precipitated with ZO-1
from cells expressing wild type Cx45 (lane 2) but not from
untransfected control cells (lane 1). Co-precipitation from two
clones expressing di¡erent amounts of the mutant Cx45 was
greatly reduced as compared to wild type Cx45 (lane 3 and 4),
even though expression levels for mutant Cx45 were three- to
four-fold higher than for the wild type protein (compare lanes
7 and 8 to lane 6). Quanti¢cation of the co-precipitation ex-
periments, taking into account the di¡erences in expression
levels, showed that the inactivation of the PDZ binding motif
in Cx45 resulted in a V20-fold reduction of the Cx45 asso-
ciated with ZO-1.
While Cx45 co-precipitated with ZO-1, ZO-1 was not read-
ily detected in Cx45 immunoprecipitates, possibly because
ZO-1 could mask the C-terminal epitope for the antibody
used to immunoprecipitate Cx45.
Thus, full length Cx45 and ZO-1 bind in vivo through a
direct interaction that requires the C-terminal PDZ binding
motif in Cx45.
3.4. Cx45 co-localizes with ZO-1 in the tight junction region in
polarized MDCK cells
Next, we determined if Cx45 and ZO-1 co-localize in fully
polarized MDCK cell monolayers. Cells were grown on per-
meable polycarbonate ¢lters to obtain polarized cell mono-
layers with well-established tight junctions. Monolayers were
¢xed, permeabilized, stained with rabbit anti-ZO-1 and mono-
clonal mouse anti-Cx45 and suitably labeled secondary anti-
bodies, and visualized by confocal microscopy. Images of hor-
izontal sections at the height of tight junctions (Fig. 3A^C)
and vertical sections along the apico-basal axis (panels D^F)
of the monolayer were acquired.
As shown in Fig. 3, control cells (panels A and D) and cells
transfected with wild type (panels B and E) or mutant (panels
C and F) Cx45 showed the typical localization of ZO-1 (red
color) to tight junctions. No staining for Cx45 (green color)
was observed in control cells (panels A and D), whereas cells
Fig. 1. Characterization of MDCK cells expressing wild type or mutant Cx45. A: Western blot analysis. Lysates of control MDCK cells (lane
1) or cells transfected with a mouse Cx45 cDNA (lane 2) or a construct in which the C-terminal SVWI residues were mutated to alanine (lane
3) were analyzed by Western blot using a monoclonal anti-Cx45 antibody. B: Immuno£uorescence analysis. Control cells or cells transfected
with wild type (Cx45) or mutant (Cx45mut) Cx45 grown on glass coverslips were ¢xed, permeabilized and stained with anti-Cx45 and labeled
anti-mouse antibodies. Arrows show the accumulation of Cx45, but not Cx45mut, at regions of cell^cell contact. Bar: 10 Wm.
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transfected with wild type (panels B and E) or mutant (panels
C and F) Cx45 showed a punctate Cx45 staining. A signi¢cant
degree of co-localization (yellow color) of Cx45 and ZO-1 was
observed in cells transfected with wild type Cx45, whereas the
localization of the mutant to tight junctions was strongly de-
creased. Nevertheless, inactivation of the PDZ binding motif
in Cx45 did not completely abolish its co-localization with
ZO-1 (see panel C, arrows), suggesting that localization of
Cx45 to the tight junction area could be mediated by other
mechanisms besides a direct association with ZO proteins (see
Section 4). Similar results were obtained for co-localization
with another tight junction marker, occludin (data not
shown).
In conclusion, Cx45 is present together with ZO-1 in the
tight junction region of MDCK cells and this localization is
mediated by the PDZ binding motif of Cx45.
4. Discussion
Using a yeast two-hybrid assay, we show that the C-termi-
nus of Cx45 interacts with the PDZ domains of ZO-1 and ZO-
3, but not those in ZO-2. Furthermore, full length Cx45 and
ZO-1 interact in vivo in epithelial MDCK cells based on co-
immunoprecipitation and co-localization experiments. The C-
terminus of Cx45 resembles classical PDZ binding motifs [14]
and mutational analysis con¢rmed the requirement of the
SVWI motif for the interaction with the PDZ domains of
ZO-1 and ZO-3, both in the yeast two-hybrid assay and
with full length ZO-1 in vivo. MDCK cells were chosen since,
in contrast to the broad distribution throughout the area of
cell^cell contact in osteoblasts or cardiac myocytes, ZO-1 is
restricted to discrete tight junctions, facilitating the interpre-
tation of co-localization experiments.
Although mutation of the SVWI dramatically reduced the
fraction of Cx45 that co-precipitated with ZO-1, the interac-
tion was not completely abolished, suggesting that mutant
Cx45 may be able to associate with ZO-1 via an alternative
mechanism. Since di¡erent connexins can assemble into a sin-
gle connexon, Cx45 may be incorporated into heteromeric
connexons containing a second connexin able to bind ZO-1.
MDCK cells express Cx43 [15], which forms heteromeric con-
nexons with Cx45 [16] and also interacts with ZO-1 [11,17].
Indeed, Cx45 has recently been detected in a complex with
Cx43 and ZO-1 [18], although this study did not conclusively
demonstrate a direct interaction between Cx45 and ZO-1.
Thus, while mutation of the PDZ binding motif in Cx45 abol-
ishes its direct interaction with ZO-1, it may still associate
Fig. 2. Cx45 directly interacts with ZO-1 via the C-terminal SVWI.
Control MDCK cells (lanes 1 and 5) or cells expressing wild type
(lanes 2 and 6) or mutant (lanes 3, 4, 7 and 8) Cx45 were lysed and
equal amounts of total protein were used to immunoprecipitate ZO-
1 (lanes 1^4). Immunoprecipitates were then analyzed by Western
blot to detect Cx45 bound to ZO-1. An aliquot of the cell lysate
was directly blotted (lanes 5^8) to determine the amount of wild
type and mutant Cx45 present in the cell lysate.
Fig. 3. Cx45 co-localizes with ZO-1 to the tight junction region in MDCK cells. Control cells (A,D) and cells transfected with wild type (B,E)
or mutant (C,F) Cx45 were grown on polycarbonate ¢lters to obtain polarized cell monolayers. Cells were ¢xed, permeabilized and stained for
Cx45 (green) and ZO-1 (red). Confocal images corresponding to horizontal sections at the height of tight junctions (A^C) or to vertical sections
along the apico-basal axis of the monolayer (D^F) were acquired. Cx45 extensively co-localizes with ZO-1 (yellow; arrows) at the level of tight
junctions (B,E). Although the co-localization of the mutant Cx45 with ZO-1 is strongly reduced (D,F), occasional co-localization is observed
(C, arrows). Bar: 10 Wm.
FEBS 25192 4-9-01 Cyaan Magenta Geel Zwart
P.J. Kausalya et al./FEBS Letters 505 (2001) 92^96 95
indirectly via Cx43. Mixed Cx43/Cx45 connexons are there-
fore likely to account for the occasional, albeit dramatically
reduced, detection of mutant Cx45 in the tight junction re-
gion.
Cx43 interacts with the second PDZ domain of ZO-1, also
via a C-terminal PDZ binding motif [17]. Several other mem-
bers of the connexin family encode putative PDZ binding
sequences at their C-termini [14], raising the possibility that
other connexins besides Cx43 and Cx45 also bind to ZO pro-
teins. In this case, di¡erent connexins could compete for a
particular PDZ domain, interact with di¡erent PDZ domains
in one ZO protein, or bind to di¡erent ZO proteins. Whether
Cx43, like Cx45, interacts with other ZO proteins is not
known.
The functional relevance of the association between connex-
ins and ZO proteins is still unclear. Connexins and ZO-1 co-
localize at sites of cell-cell contact in a variety of cell types,
including cardiac myocytes (Cx43 [11]), ¢broblasts (Cx43
[17]), osteoblasts (connexin 43 and 45 [19]), kidney epithelial
cells (Cx45, this report) and hepatocytes (Cx32 [20]). ZO-1 or
other ZO proteins could therefore play a role in targeting or
localizing connexins to specialized plasma membrane do-
mains. Indeed, di¡erent connexins are restricted to specialized
plasma membrane domains in many cell types, including
Schwann cells [9,10] and cardiac myocytes [11]. In addition
to osteoblasts and myocytes, Cx45 is expressed in endothelial
cells, which can establish ZO-1-containing tight junctions. In-
terestingly, mice de¢cient for Cx45 show severe defects in
blood vessel maturation [21].
ZO proteins may also play a role in connexon assembly and
stability. The close opposition of the plasma membranes of
adjacent epithelial cells at tight junctions, for example, may
facilitate the formation of gap junctions between neighboring
cells. Alternatively, binding to ZO proteins could determine
which connexin types co-assemble into a particular connexon.
Interestingly, over-expression of Cx32 in hepatocytes increases
the number and complexity of tight junction strands and small
gap junction plaques are observed between strands [20].
Although Cx32 is associated with occludin [20], it is not
known if this interaction is direct or via a ZO protein. An
increased turnover rate observed for a Cx43 mutant that no
longer binds ZO-1 [22] also supports a role of ZO proteins in
stabilizing connexons, possibly by tethering them to the actin
cytoskeleton.
The observation that ZO-1 only co-localizes with a subset
of the total cellular connexin protein implicates the presence
of distinct connexon populations in a single cell, which could
di¡er in function or mode of regulation. Recent evidence sup-
ports a role for ZO proteins in signal transduction events,
possibly as platforms to assemble signaling molecules [23].
Thus, ZO proteins associated with gap junctions could serve
to recruit signaling molecules involved in the regulation of
intercellular communication.
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